New Edge Wealth, LLC Immuno Gen, Inc. Transaction History

New Edge Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $1,980 - $2,859	-442 Reduced 3.83%	11,088 $53,000
Q2 2022 Aug 09, 2022	BUY	$3.15 - $5.76 $36,319 - $66,412	11,530 New	11,530 $52,000
Q2 2021 Aug 11, 2021	SELL	$5.79 - $8.6 $95,882 - $142,416	-16,560 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.5 - $10.53 $107,640 - $174,376	16,560 New	16,560 $134,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Wealth, LLC with notifications on news.